Synergy Biomedical Launches BIOSPHERE MIS PUTTY
Synergy Biomedical received FDA 510(k) clearance and commenced full launch of BIOSPHERE® MIS PUTTY for open, mini-open and percutaneous minimally invasive procedures....
Sep 21, 2018,
Synergy Biomedical Launches BIOSPHERE MIS PUTTY
Medtronic to Acquire Mazor Robotics
Medtronic entered into a definitive agreement to acquire Mazor Robotics for US $1.64BB in cash in a transaction that is slated to...
Sep 21, 2018,
SI-BONE Files for Proposed IPO
SI-BONE publicly filed for a proposed IPO, and applied to list on NASDAQ as SIBN. Proceeds will primarily support commercialization...
Sep 21, 2018,
Joint Reconstruction Expected to Continue with Steady Growth
The 1H18 performance of companies that make up ~80% of the joint reconstruction market achieved 4.1% growth vs. 1H17. These...
Sep 21, 2018,
Spine Company M&A Picks Up in 3Q18
We've tracked 31 mergers and acquisitions in the spine space from 2017 through mid-September 2018...
Sep 21, 2018,
joimax Introduces Intracs Electromagnetic Navigation
joimax is debuting the Intracs®em Electromagnetic Navigation system for endoscopic spinal surgery prior to its 4Q18 launch in Europe....
Sep 20, 2018,
Providence Medical Technology Secures $25MM in Equity Financing
Providence Medical Technology closed US $25MM in new equity financing. Proceeds will support market expansion and clinical development of DTRAX®...
Sep 20, 2018,
NICE Recommendation for TranS1 AxiaLIF in the UK
TranS1 announced NICE recommendation for approval of the AxiaLIF® system and presacral approach among standard arrangments to treat severe chronic low back...
Sep 19, 2018,
SpineEx Files for $17MM IPO
SpineEx filed to raise up to US $17MM in an initial public offering to support commercialization of spinal devices, including an...
Sep 19, 2018,
Meditech Spine Gains FDA Clearance for Cure Opel-C Plating System
Meditech Spine gained FDA 510(k) clearance to market the CURE Opel-C Plate implant system, an add-on technology to its CURE...
Sep 18, 2018,
Loading new posts...
No more posts
